ReviewAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Peroxidase-Mimicking Nanozymes for Rapid Detection of Infectious Diseases.
Review in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Nanozymes: bridging nanoscale characteristics and catalytic mechanisms for advanced biomedical applications.Journal of enzyme inhibition and medicinal chemistry · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Infectious diseases pose a critical global health threat, and rapid and sensitive diagnostics are essential for effective intervention. Conventional methods are often slow, costly, and require centralized instrumentation and trained personnel, limiting timely decision-making. Peroxidase-mimicking nanozymes (PMNs) have emerged as powerful alternatives to natural peroxidases, enabling the development of rapid, sensitive, and robust diagnostic platforms. The superior performance of these platforms is rooted in the well-defined structural and compositional features of PMNs, which endow them with high peroxidase-like activity to catalyze substrate oxidation into easily detectable signals. Furthermore, the unique physicochemical properties of PMNs support the design of simplified workflows, miniaturized point-of-care devices, and novel sensing logics that are inaccessible to conventional protein enzymes. This review highlights structure-activity relationships guiding PMN design, synthetic strategies for constructing these nanozymes, their integration into biosensing platforms for infectious disease detection, and the role of artificial intelligence in PMN design and biosensing applications. By focusing on the interplay between PMN materials and sensing technologies, we illustrate how these systems advance rapid, sensitive, and cost-effective diagnostics. We also provide our perspective on the broader societal impact of PMN-enabled infectious disease diagnostics, along with the challenges and opportunities that shape their translation toward practical clinical use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.